SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-276373
Filing Date
2022-11-03
Accepted
2022-11-03 07:16:03
Documents
20
Period of Report
2022-11-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d408638d8k.htm   iXBRL 8-K 46113
2 EX-4.1 d408638dex41.htm EX-4.1 89518
3 EX-5.1 d408638dex51.htm EX-5.1 7752
4 EX-10.1 d408638dex101.htm EX-10.1 148349
5 EX-10.2 d408638dex102.htm EX-10.2 463387
6 EX-99.1 d408638dex991.htm EX-99.1 12610
10 GRAPHIC g408638g1102132219473.jpg GRAPHIC 2409
11 GRAPHIC g408638g1102132225587.jpg GRAPHIC 2406
12 GRAPHIC g408638g1103012142141.jpg GRAPHIC 4409
  Complete submission text file 0001193125-22-276373.txt   1093912

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA kura-20221102.xsd EX-101.SCH 2872
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20221102_lab.xml EX-101.LAB 17995
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20221102_pre.xml EX-101.PRE 11272
14 EXTRACTED XBRL INSTANCE DOCUMENT d408638d8k_htm.xml XML 3353
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37620 | Film No.: 221356199
SIC: 2834 Pharmaceutical Preparations